Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo Rizzari

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Pediatric Blood & Cancer|April 19, 2019
Nationwide central diagnosis review for childhood solid tumors: From concept to realization of an Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) integrated projectFilippo Spreafico, Paola Quarello, Rita Alaggio, et al.
Frontiers in Pediatrics|June 3, 2026
The very rare association between T-cell acute lymphoblastic leukemia and down syndrome: a case report and review of the literatureGiacomo Gotti, Laura Rachele Bettini, Stefano Rebellato, et al.
Pathogens & Immunity|September 21, 2019
Combination Antifungal Therapy for Invasive Mold Infections Among Pediatric Patients with Hematological Malignancies: Data from A Real-Life Case-SeriesAnna Maria Peri, Marta Verna, Stefano Biffi, et al.
British Journal of Haematology|September 12, 2018
A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemiaC Michel Zwaan, Stefan Söderhäll, Benoit Brethon, et al.
Pediatric Blood & Cancer|June 28, 2025
First-Line Postremission Blinatumomab as Successful Toxicity-Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic LeukemiaNicolò Peccatori, Benedetta Elena Di Majo, Laura Claut, et al.
Pediatric Blood & Cancer|May 13, 2022
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase productCristina Matteo, Antonella Colombini, Laura Rachele Bettini, et al.
Genes|March 25, 2022
Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a ChildMartha Caterina Faraguna, Francesca Musto, Viola Crescitelli, et al.
The Lancet Regional Health. Europe|January 14, 2025
Do national cancer control plans address care and research for children, adolescents, and young adults? A review of status, priorities, and recommendations across 41 European countriesJoan Prades, Olga Kozhaeva, Maria Otth, et al.
Haematologica|April 13, 2004
Outcome of very late relapse in children with acute lymphoblastic leukemiaCarmelo Rizzari, Maria Grazia Valsecchi, Maurizio Aricò, et al.
Therapeutic Drug Monitoring|February 6, 2020
Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 StudyGudrun Würthwein, Claudia Lanvers-Kaminsky, Joachim Gerss, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Pediatric Blood & Cancer|April 19, 2019
Nationwide central diagnosis review for childhood solid tumors: From concept to realization of an Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) integrated projectFilippo Spreafico, Paola Quarello, Rita Alaggio, et al.
Frontiers in Pediatrics|June 3, 2026
The very rare association between T-cell acute lymphoblastic leukemia and down syndrome: a case report and review of the literatureGiacomo Gotti, Laura Rachele Bettini, Stefano Rebellato, et al.
Pathogens & Immunity|September 21, 2019
Combination Antifungal Therapy for Invasive Mold Infections Among Pediatric Patients with Hematological Malignancies: Data from A Real-Life Case-SeriesAnna Maria Peri, Marta Verna, Stefano Biffi, et al.
British Journal of Haematology|September 12, 2018
A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemiaC Michel Zwaan, Stefan Söderhäll, Benoit Brethon, et al.
Pediatric Blood & Cancer|June 28, 2025
First-Line Postremission Blinatumomab as Successful Toxicity-Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic LeukemiaNicolò Peccatori, Benedetta Elena Di Majo, Laura Claut, et al.
Pediatric Blood & Cancer|May 13, 2022
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase productCristina Matteo, Antonella Colombini, Laura Rachele Bettini, et al.
Genes|March 25, 2022
Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a ChildMartha Caterina Faraguna, Francesca Musto, Viola Crescitelli, et al.
The Lancet Regional Health. Europe|January 14, 2025
Do national cancer control plans address care and research for children, adolescents, and young adults? A review of status, priorities, and recommendations across 41 European countriesJoan Prades, Olga Kozhaeva, Maria Otth, et al.
Haematologica|April 13, 2004
Outcome of very late relapse in children with acute lymphoblastic leukemiaCarmelo Rizzari, Maria Grazia Valsecchi, Maurizio Aricò, et al.
Therapeutic Drug Monitoring|February 6, 2020
Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 StudyGudrun Würthwein, Claudia Lanvers-Kaminsky, Joachim Gerss, et al.
Pageof 15